Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
14,624
-1,838
-11% -$153K 0.03% 472
2025
Q4
$1.42M Sell
16,462
-2,161
-12% -$189K 0.03% 416
2025
Q3
$1.71M Buy
18,623
+3,601
+24% +$336K 0.04% 380
2025
Q2
$1.5M Sell
15,022
-12,088
-45% -$1.29M 0.04% 433
2025
Q1
$2.85M Buy
27,110
+16,644
+159% +$1.63M 0.04% 409
2024
Q4
$825K Buy
10,466
+6,268
+149% +$486K 0.03% 462
2024
Q3
$312K Sell
4,198
-5,540
-57% -$484K 0.01% 652
2024
Q2
$912K Buy
9,738
+589
+6% +$55.8K 0.04% 378
2024
Q1
$957K Buy
9,149
+6,412
+234% +$591K 0.04% 361
2023
Q4
$248K Sell
2,737
-4,132
-60% -$315K 0.01% 619
2023
Q3
$560K Sell
6,869
-419
-6% -$31.8K 0.03% 442
2023
Q2
$505K Buy
7,288
+378
+5% +$28.7K 0.03% 460
2023
Q1
$596K Sell
6,910
-295
-4% -$22.5K 0.04% 407
2022
Q4
$492K Buy
7,205
+1,377
+24% +$78.6K 0.03% 426
2022
Q3
$331K Buy
5,828
+721
+14% +$62K 0.02% 477
2022
Q2
$490K Buy
5,107
+70
+1% +$7.56K 0.02% 501
2022
Q1
$760K Sell
5,037
-2,603
-34% -$467K 0.03% 434
2021
Q4
$1.71M Buy
7,640
+993
+15% +$237K 0.07% 278
2021
Q3
$1.58M Buy
6,647
+2,516
+61% +$625K 0.06% 285
2021
Q2
$1M Buy
4,131
+25
+0.6% +$6.03K 0.04% 366
2021
Q1
$1.11M Buy
4,106
+1,336
+48% +$336K 0.03% 397
2020
Q4
$588K Sell
2,770
-192
-6% -$45.6K 0.02% 494
2020
Q3
$640K Sell
2,962
-10
-0.3% -$2.08K 0.03% 377
2020
Q2
$604K Sell
2,972
-397
-12% -$67.4K 0.03% 374
2020
Q1
$407K Sell
3,369
-300
-8% -$37.6K 0.03% 416
2019
Q4
$439K Buy
3,669
+160
+5% +$18.4K 0.02% 464
2019
Q3
$340K Buy
3,509
+647
+23% +$80.8K 0.02% 498
2019
Q2
$353K Sell
2,862
-25
-0.9% -$2.71K 0.02% 508
2019
Q1
$238K Buy
2,887
+180
+7% +$14.2K 0.02% 586
2018
Q4
$166K Hold
2,707
0.01% 657
2018
Q3
$190K Buy
2,707
+200
+8% +$11.9K 0.01% 661
2018
Q2
$126K Buy
2,507
+692
+38% +$32.9K 0.01% 711
2018
Q1
$72K Buy
+1,815
New +$60.6K 0.01% 861

Other funds holding OKTA

Geneos Wealth Management's OKTA Position: Q1 2026 in Review

Geneos Wealth Management reduced its Okta (OKTA) stake by 11% in Q1 2026, selling an estimated $153K and leaving 14,624 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #472.

Geneos Wealth Management first reported a position in OKTA in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.85M in Q1 2025. 730 funds tracked by Wall St. Rank hold OKTA as of Q1 2026.

  • Geneos Wealth Management held 14,624 shares of Okta worth $1.15M as of Q1 2026.
  • Geneos Wealth Management sold 1,838 Okta shares in Q1 2026, an estimated $153K.
  • Okta made up 0.03% of Geneos Wealth Management's portfolio in Q1 2026, its #472 holding.
  • Geneos Wealth Management first reported a position in Okta in Q1 2018 and has held it in 33 quarters since.
  • Geneos Wealth Management's Okta position peaked at $2.85M in Q1 2025.
  • 730 funds tracked by Wall St. Rank held Okta as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.